Basecamp Research has launched a new scientific initiative, called the Trillion Gene Atlas, to bring together genomic data ...

An appeals court in the US has said that AbbVie, AstraZeneca, Novartis, and Sanofi will have to defend claims they defrauded ...

Johnson & Johnson's much-anticipated oral IL-23 inhibitor, icotrokinra, has claimed FDA approval as a first-line treatment ...

Over the past decade, pharma has made digital health a strategic priority, launching patient apps, HCP platforms, adherence ...

The aligned pathway for UK drugs regulator MHRA and reimbursement authority NICE – aimed at slashing the time it takes for ...

Ask a pharma commercial team where lung cancer patients are treated in France and most will point to major academic centres ...

A phase 2 trial has shown promising protective efficacy for what could become the first vaccine against hookworm, a parasitic ...

This breakthrough has accelerated peptide drug development across multiple therapeutic areas, including cardiovascular ...

Roche has ramped up its investment in NVIDIA's AI chips, launching an upscaled hybrid-cloud AI factory that it believes is ...

In a new pharmaphorum podcast, web editor Nicole Raleigh was joined by Rob DiCicco, vice president of portfolio management at ...

The US regulator has cleared its Arexvy RSV shot for adults in that age group who are at increased ​risk of lower respiratory ...

AstraZeneca's cancer immunotherapy Imfinzi has been approved in the EU for use before and after surgery for early-stage ...